Optimizing the End-to-End Usage of Cell-based & Biophysical Analytical Methods to Enhance ADC Characterization & Demonstrate Drug Potency & Homogeneity to Obtain Regulatory Approval

As ADCs continue to see clinical success, and as drug design becomes more complex, regulatory scrutiny to ensure product quality is increasing. The trailblazing ADC Analytical Development Summit was the first and only industry focused meeting dedicated to addressing the unique challenges faced by analytical, CMC, QC, process development and protein characterization experts working on ADCs.

Covering the end-to-end development and application of analytical technologies in a phase-dependent manner, this novel meeting focused on enhancing ADC characterization, understanding drug potency and demonstrating homogeneity to support regulatory requirements.

With the sharing of unique insights into novel method development, CQAs, bioassays, DAR quantification and distribution, and platform approaches, this meeting offered attendees the unmissable opportunity to get up to speed with this rapidly growing field and to support safe, consistent and high quality ADC development.

View the 2022 event guide here

A Snapshot of our 2022 Expert Speaker Faculty:

A Sample of Companies Who Attended in 2022:

Companies Attending the ADC Analytical Development Summit

Other Events in the Series: